VNS Devices

Vagal nerve stimulation VNS devices represent the convergence of neuroscience and consumer wearable technology delivering targeted electrical vibrational or acoustic stimulation to activate the vagus nerve and shift the autonomic nervous system from sympathetic stress to parasympathetic rest dominance. Three leading devices Pulsetto Apollo Neuro and Sensate each take distinct approaches to achieving this outcome. Pulsetto uses bilateral cervical VNS delivering low-frequency electrical pulses to the neck via gel-lined electrodes. With over 100000 verified users as of 2026 Pulsetto published pilot study data showing that 4 weeks of daily use produced a 45 percent reduction in anxiety scores 56 percent reduction in depressive symptoms and 41 percent reduction in sleep disturbances. Independently 86 percent of users reported feeling calmer and 80 percent reported improved sleep. Apollo Neuro delivers silent vibrations through the wrist or ankle in 7 distinct frequency modes designed to communicate safety signals to the vagus nerve. The device is engineered around the principle that low-frequency vibrations mimic the physiological patterns associated with states of safety and social engagement directly targeting the polyvagal system described by Dr. Stephen Porges. Sustained Apollo Neuro use produces measurable HRV improvements within 30 days. Sensate uses infrasonic acoustic resonance delivered via a sternum-placed device paired with soundscapes. A 28-day study found 48 percent stress reduction and participants gaining 45 to 60 extra minutes of sleep per night. Neurologically all three devices exploit the vagus nerve role as the primary parasympathetic superhighway because 80 percent of its fibers run afferent body to brain peripheral stimulation carries strong regulatory signals directly to the brainstem and limbic system producing measurable shifts in anxiety HRV and sleep architecture without pharmacological intervention.